Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats

References

• Akash MSH, Rehman K, Li N, et al. (2012). Sustained delivery of IL-1Ra from Pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res 29:3475–85
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. (1999). Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm 184:189–98
   PubMed Web of Science ®Google Scholar
• Bhardwaj R, Blanchard J. (1996). Controlled-release delivery system for the a-MSH analog melanotan-I using Poloxamer 407. J Pharm Sci 85:915–9
   PubMed Web of Science ®Google Scholar
• Blonder JM, Baird L, Fulfs JC, Rosenthal GJ. (1999). Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. Life Sci 65:261–6
   Web of Science ®Google Scholar
• Charman SA, Segrave AM, Edwards GA, Porter CJH. (2000). Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection. J Pharm Sci 89:168–77
   PubMed Web of Science ®Google Scholar
• Choi HG, Jung JH, Ryu JM, et al. (1998). Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 165:33–44
   Web of Science ®Google Scholar
• Chung TW, Liu DZ. (2010). Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: in vitro characterization and in vivo study. Carbohydr Polym 82:316–22
   Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82
   PubMed Web of Science ®Google Scholar
• Gong C, Qi T, Wei X, et al. (2013). Thermosensitive polymeric hydrogels as drug delivery systems. Curr Med Chem 20:79–94
   PubMed Web of Science ®Google Scholar
• Johnston TP, Miller IR. (1985). Toxicological evaluation of poloxamer vehicles for intramuscular use. J Parenter Sci Technol 39:83–9
   PubMedGoogle Scholar
• Johnston TP, Punjabi MA, Froelich CJ. (1992). Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res 9:425–34
   PubMed Web of Science ®Google Scholar
• Katakam M, Ravis WR, Banga AK. (1997). Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels. J Contr Rel 49:21–6
   Web of Science ®Google Scholar
• Klouda L, Mikos AG. (2008). Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68:34–45
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu WL, Wang JC, et al. (2007). Controlled delivery of recombinant hirudin based on thermosensitive pluronic® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization. J Contr Rel 117:387–95
   PubMed Web of Science ®Google Scholar
• Matthew JE, Nazario YL, Roberts SC. (2002). Effect of mammalian cell culture medium on the gelation properties of Pluronic PF127. Biomaterials 23:4615–9
   PubMed Web of Science ®Google Scholar
• Nie S, Hsiao WW, Pan W, Yang Z. (2011). Thermosensitive pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomed 6:151–61
   PubMed Web of Science ®Google Scholar
• Paavola A, Kilpelainen I, Yliruusi J, Rosenberg P. (2000). Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int J Pharm 199:85–93
   PubMed Web of Science ®Google Scholar
• Palmer WK, Emeson EE, Johnston TP. (1998). Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. Atherosclerosis 136:115–23
   PubMed Web of Science ®Google Scholar
• Pec EA, Wout ZG, Johnston TP. (1992). Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J Pharm Sci 81:626–30
   PubMed Web of Science ®Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–11
   PubMedGoogle Scholar
• Rassing J, Mckenna W, Bandyopadhyay S, Eyring E. (1984). Ultrasonic and 13C-NMR studies on gel formation in aqueous solution of ABA block copolymeric Pluronic F-127. J Mol Liq 27:165–78
   Web of Science ®Google Scholar
• Rouini MR, Atyabi F, Foroumadi A, et al. (2013). In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. Eur J Pharm Sci 48:87–96
   PubMed Web of Science ®Google Scholar
• Ruel-Gariépy E, Leroux JC. (2004). In situ-forming hydrogels—review of temperature-sensitive systems. Eur J Pharm Biopharm 58:409–26
   PubMed Web of Science ®Google Scholar
• Seymour LW. (1992). Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 9:135–87
   PubMed Web of Science ®Google Scholar
• Sun GL, Lin X, Hong YL, et al. (2012). PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium. Eur J Pharm Sci 46:545–52
   PubMed Web of Science ®Google Scholar
• Supersaxo A, Hein W, Gallati H, Steffen H. (1988). Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application. Pharm Res 5:472–6
   PubMed Web of Science ®Google Scholar
• Supersaxo A, Hein WR, Steffen H. (1990). Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res 7:167–9
   PubMed Web of Science ®Google Scholar
• Veyries ML, Couarraze G, Geiger S, et al. (1999). Controlled release of vancomycin from poloxamer gels. Int J Pharm 192:183–93
   PubMedGoogle Scholar
• Wei G, Lu LF, Zhong GR, et al. (2006). A probe study on thermosensitive in situ gel as carrier of injectable sustained-release protein delivery system. Chin J Pharm 37:597–601
   Google Scholar
• Wenzel JGW, Balaji KSS, Koushik K, et al. (2002). Pluronic F127 gel formulations of Deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle. J Contr Rel 85:51–9
   PubMed Web of Science ®Google Scholar
• Wout ZGM, Pec EA, Maggiore JA, et al. (1992). Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. J Parent Sci Technol 46:192–200
   PubMedGoogle Scholar
• Wright JM, Burgess DJ, eds. (2011). Acting injections and implants, advances in delivery science and technology. Berlin, Germany: Springer
   Google Scholar
• Zhang L, Parsons DL, Navarre C, Kompella UB. (2002). Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J Contr Rel 85:73–81
   PubMed Web of Science ®Google Scholar